Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Cosel Co., Ltd. is a Japanese manufacturer of AC-DC and DC-DC power supplies, primarily serving industrial automation, medical equipment, and telecommunications markets. The company operates manufacturing facilities in Japan and Asia, competing in a fragmented market against larger players like TDK-Lambda and Delta Electronics. The stock is currently experiencing significant operational stress with negative margins and sharp revenue contraction, though exceptionally high current ratio suggests strong liquidity position.
Cosel generates revenue through sale of standardized and custom-engineered power conversion products with typical gross margins in the 25-30% range. The business model relies on technical differentiation through high-efficiency designs, compact form factors, and reliability certifications (medical, industrial safety standards). Pricing power is moderate, constrained by competition from larger Asian manufacturers and commoditization pressure in standard product lines. The company maintains customer relationships through design-in cycles where power supplies are specified into end-customer products, creating switching costs. Current 26.6% gross margin is within historical range, but 2.3% operating margin and negative net margin indicate severe operating leverage challenges, likely from fixed manufacturing overhead absorption issues during the 34.7% revenue decline.
Industrial capital expenditure cycles in Japan and Asia - factory automation buildouts drive demand for industrial power supplies
Medical equipment OEM order rates - long lead-time design wins with diagnostic imaging and medical device manufacturers
Yen exchange rate fluctuations (USD/JPY) - affects competitiveness of Japanese manufacturing exports and translation of overseas revenue
Component cost inflation - particularly for semiconductors, magnetics, and capacitors which represent 50-60% of COGS
Capacity utilization rates - given high fixed cost base, production volume directly impacts margin performance
Commoditization of standard power supply products - increasing competition from Chinese manufacturers (Meanwell, Mornsun) offering lower-cost alternatives erodes pricing power in non-differentiated product lines
Technological shift toward integrated power management - semiconductor companies (Texas Instruments, Analog Devices) integrating power conversion into system-on-chip solutions reduces addressable market for discrete power supplies
Energy efficiency regulations - while creating opportunities, also require continuous R&D investment to maintain compliance with evolving standards (80 PLUS, Energy Star, EU efficiency directives)
Market share pressure from larger diversified competitors - TDK-Lambda, Delta Electronics, and Murata have greater scale, broader product portfolios, and stronger customer relationships with major OEMs
Customer concentration risk - dependence on major industrial automation and medical OEMs creates vulnerability to customer consolidation or design losses to competitors
Geographic concentration in mature Japanese market - limited exposure to faster-growing emerging markets compared to Taiwan and Chinese competitors
Negative profitability sustainability - current -0.4% net margin and -0.7% ROE indicate company is destroying shareholder value; extended losses could erode equity base despite strong current liquidity
Working capital inefficiency - exceptionally high 16.18x current ratio suggests excess cash or inventory buildup, indicating potential operational inefficiencies or demand forecasting issues
Capex intensity relative to revenue - $1.8B capex on $27.1B revenue (6.6% ratio) appears elevated for a company with declining sales, raising questions about capital allocation discipline
high - Power supply demand is directly tied to industrial capital spending cycles, factory automation investments, and medical equipment production. The 34.7% revenue decline likely reflects broader industrial recession in key Asian markets and inventory destocking by OEM customers. Recovery depends on resumption of capex spending in manufacturing sectors. Industrial production indices in Japan, China, and broader Asia are primary leading indicators.
moderate - Rising rates negatively impact customer capex budgets, particularly for discretionary factory automation projects. However, Cosel's zero debt position eliminates direct financing cost sensitivity. Higher rates primarily affect valuation multiples and customer investment decisions rather than company operations. The 16.18x current ratio suggests no refinancing risk.
minimal - With zero debt-to-equity ratio and exceptionally strong current ratio of 16.18x, Cosel has no meaningful credit exposure. The company is not dependent on credit markets for operations or growth. However, customer credit quality matters as OEM customers may delay payments or cancel orders during economic stress.
value - Current 1.0x price-to-book and 2.3x price-to-sales with 659% FCF yield suggest deep value opportunity for contrarian investors betting on cyclical recovery. However, negative profitability and severe revenue decline create significant turnaround risk. Primarily attracts Japanese value investors and special situations funds willing to hold through industrial cycle trough. Not suitable for growth or income investors given negative earnings and likely dividend suspension.
high - Small-cap industrial cyclical with $0.3B market cap exhibits elevated volatility. Stock performance highly correlated with Japanese industrial sector and Asian manufacturing cycles. Limited liquidity as Japanese small-cap with minimal international investor coverage amplifies price swings. Recent 9.7% returns across 3/6/12-month periods suggest range-bound trading during earnings trough.
